China has quietly compiled a “whitelist” of U.S.-made products that will be exempted from its steep 125% retaliatory tariffs, in a significant — though unpublicized — move aimed at easing domestic pressure from the ongoing trade war with Washington.

While China has already granted exemptions for certain items, including specific pharmaceuticals, microchips, aircraft engines, and more recently U.S. ethane, this is the first time the existence of a broader, classified exemption list has been reported. Rather than announce the exemptions publicly, Chinese authorities have chosen a discreet approach, directly notifying selected companies and inviting others to inquire privately about the exemption status of their products.

The ongoing debt crisis in the Chinese property market is now posing a significant challenge for offshore creditors of Chinese property developers. The prospects of debt restructuring terms being tightened have increased due to the deteriorating outlook for the real estate sector in…

India now finds itself navigating one of the most delicate strategic and economic balancing acts in its modern history, caught between two rival superpowers on which its own growth prospects depend, yet which are increasingly at odds with each other. The United States has slapped tariffs of 50% on most Indian exports, delivering a shock to New Delhi’s trade apparatus.

At the same time, India remains structurally reliant on China in crucial supply chains despite a bitter political relationship in recent years, and is now tentatively seeking to thaw ties with Beijing as a way to shore up its industrial base. How India manages this dual challenge will shape not just its own development trajectory, but the wider geopolitical balance across the Indo-Pacific.